| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1531 | 2015 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 398 | 2013 |
| Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease I Baldeiras, I Santana, MT Proença, MH Garrucho, R Pascoal, ... Journal of Alzheimer's Disease 15 (1), 117-128, 2008 | 199 | 2008 |
| Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease SI Mota, RO Costa, IL Ferreira, I Santana, GL Caldeira, C Padovano, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (7 …, 2015 | 189 | 2015 |
| Mitochondrial‐and Endoplasmic Reticulum‐Associated Oxidative Stress in Alzheimer′ s Disease: From Pathogenesis to Biomarkers E Ferreiro, I Baldeiras, IL Ferreira, RO Costa, AC Rego, CF Pereira, ... International Journal of Cell Biology 2012 (1), 735206, 2012 | 181 | 2012 |
| Metabolic alterations induced by sucrose intake and Alzheimer’s disease promote similar brain mitochondrial abnormalities C Carvalho, S Cardoso, SC Correia, RX Santos, MS Santos, I Baldeiras, ... Diabetes 61 (5), 1234-1242, 2012 | 174 | 2012 |
| Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 168 | 2018 |
| Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia AH Simonsen, SK Herukka, N Andreasen, I Baldeiras, M Bjerke, ... Alzheimer's & Dementia 13 (3), 274-284, 2017 | 166 | 2017 |
| Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment SK Herukka, AH Simonsen, N Andreasen, I Baldeiras, M Bjerke, ... Alzheimer's & Dementia 13 (3), 285-295, 2017 | 152 | 2017 |
| Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet MV Machado, P Ravasco, L Jesus, P Marques-Vidal, CR Oliveira, ... Scandinavian journal of gastroenterology 43 (1), 95-102, 2008 | 129 | 2008 |
| Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation MR Almeida, MC Macário, L Ramos, I Baldeiras, MH Ribeiro, I Santana Neurobiology of aging 41, 200. e1-200. e5, 2016 | 114 | 2016 |
| Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study IS van Maurik, SJ Vos, I Bos, FH Bouwman, CE Teunissen, P Scheltens, ... The Lancet Neurology 18 (11), 1034-1044, 2019 | 113 | 2019 |
| Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic M Schmitz, E Ebert, K Stoeck, A Karch, S Collins, M Calero, T Sklaviadis, ... Molecular neurobiology 53, 2189-2199, 2016 | 112 | 2016 |
| Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance S Cardoso, RX Santos, SC Correia, C Carvalho, MS Santos, I Baldeiras, ... Neurobiology of disease 49, 1-12, 2013 | 107 | 2013 |
| Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment I Baldeiras, I Santana, MT Proença, MH Garrucho, R Pascoal, ... Journal of Alzheimer's disease 21 (4), 1165-1177, 2010 | 100 | 2010 |
| Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment I Baldeiras, I Santana, MJ Leitão, H Gens, R Pascoal, M Tábuas-Pereira, ... Alzheimer's research & therapy 10, 1-15, 2018 | 96 | 2018 |
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease N Mattsson, C Groot, WJ Jansen, SM Landau, VL Villemagne, ... Alzheimer's & Dementia 14 (7), 913-924, 2018 | 81 | 2018 |
| Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases I Zerr, M Schmitz, A Karch, A Villar-Piqué, E Kanata, E Golanska, ... Alzheimer's & Dementia 14 (6), 751-763, 2018 | 77 | 2018 |
| Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients IE Baldeiras, MH Ribeiro, P Pacheco, A Machado, I Santana, L Cunha, ... Journal of neurology 256, 1540-1550, 2009 | 77 | 2009 |
| Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia F Llorens, P Hermann, A Villar-Piqué, D Diaz-Lucena, K Nägga, ... Nature communications 11 (1), 619, 2020 | 73 | 2020 |
Miguel Tábuas PereiraCentro Hospitalar e Universitário de Coimbra在 chuc.min-saude.pt 的电子邮件经过验证
